Abstract
Type 2 inflammation is prevalent in children with asthma and increases susceptibility to respiratory infections.1 Furthermore, acute airway infections usually precede asthma exacerbations in children.2 Consequently, an ideal therapeutic strategy should be targeted to dampen inflammation and prevent infections. There is also evidence to suggest that children with asthma have intestinal and respiratory dysbiosis that promotes airway inflammation and allergy.3 It is speculated that probiotics could restore “eubiosis,” dampen inflammation, and prevent infections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
